Tyco/Bard
This article was originally published in The Gray Sheet
Executive Summary
Ongoing discussions between Tyco and the Securities and Exchange Commission regarding the anti-trust implications of its $3.2 bil. agreement to buy C.R. Bard will push the anticipated closing date for the merger from Jan. 31 to March 31 (1"The Gray Sheet" Nov. 19, 2001, In Brief)...
You may also be interested in...
Tyco/C.R.Bard
Ongoing discussions with the Federal Trade Commission regarding Tyco's pending acquisition of Bard under a $3.2 bil. May deal will delay completion, which is now not expected before the first quarter of 2002, Bard says. The merger, which had been expected to close by year-end, likely has drawn scrutiny of overlap in the urology field, mainly in areas such as Foley catheters, and could result in a possible divestiture of part of the business...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.